Biological pathways involved in the aggressive behavior of the keratocystic odontogenic tumor and possible implications for molecular oriented treatment - An overview

Oral Oncology

Volumn 46, Issue 1, 2010, Pages 19-24

  Mendes, Rui Amaral ^a,b   Carvalho, João FC ^a   Waal, Isaac van der ^c  

^a U Porto   (Portugal)

^b UNIVERSITY INSTITUTE OF HEALTH SCIENCES IUCS   (Portugal)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Keratocyst; Keratocystic odontogenic tumor; Odontogenic neoplasm

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLINE; CYCLOOXYGENASE 2 INHIBITOR; CYCLOPAMINE; FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; INTERLEUKIN 8; KI 67 ANTIGEN; N (3 METHOXYBENZYL) 3,3 DIMETHYL N [1 (3,4 METHYLENEDIOXYBENZYL) 2 (1 PIPERAZINYLCARBONYL) 4 PYRROLIDINYL]BUTYRAMIDE; PROTEIN BCL 2; PROTEIN P53; PROTEIN PATCHED; SMOOTHENED PROTEIN; SONIC HEDGEHOG PROTEIN; THYMIDINE DERIVATIVE; THYMIDINE DINUCLEOTIDE; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BASAL CELL CARCINOMA; CANCER INVASION; CELL PROLIFERATION; DRUG TARGETING; GENETIC ASSOCIATION; HUMAN; INFLAMMATION; KERATOCYSTIC ODONTOGENIC TUMOR; MOLECULAR DYNAMICS; NONHUMAN; ODONTOGENIC TUMOR; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR PROMOTION;

APOPTOSIS; FEMALE; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; JAW NEOPLASMS; MALE; ODONTOGENIC CYSTS; ODONTOGENIC TUMORS; SIGNAL TRANSDUCTION;

EID: 72149085704     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2009.10.009     Document Type: Review

References (107)

1. Philipsen H.P. Om keratocystedr (Kolesteratomer) and kaeberne. Tandlaegebladet 60 (1956) 963-971
2. Barnes L, Eveson JW, Reichart P, et al., editors. World health organization classification of tumors. Pathology and genetics of head and neck tumors. Lyon: IARC Press; 2005.
3. Shear M, Speight PM, editors. Cysts of the oral and maxillofacial regions. 4th ed. Oxford: Blackwell Munksgaard; 2007.
4. Agaram N.P., Collins B.M., Barnes L., Lomago D., Aldeeb D., Swalsky P., et al. Molecular analysis to demonstrate that odontogenic keratocysts are neoplastic. Arch Pathol Lab Med 128 (2004) 313-317
5. Kolár Z., Geierová M., Bouchal J., Pazdera J., Zboril V., and Tvrdý P. Immunohistochemical analysis of the biological potential of odontogenic keratocysts. J Oral Pathol Med 35 (2006) 75-80
6. Regezi J.A. Odontogenic cysts, odontogenic tumors, fibroosseous, and giant cell lesions of the jaws. Mod Pathol 15 (2002) 331-341
7. Makowski G.J., McGuff S., and Van Sickels J.E. Squamous cell carcinoma in a maxillary odontogenic keratocyst. J Oral Maxillofac Surg 59 (2001) 76-80
8. Anand V.K., Arrowood Jr. J.P., and Krolls S.O. Malignant potential of the odontogenic keratocyst. Otolaryngol Head Neck Surg 111 (1994) 124-129
9. Shear M. The aggressive nature of the odontogenic keratocyst: is it a benign cystic neoplasm? Part 1. Clinical and early experimental evidence of aggressive behaviour. Oral Oncol 38 (2002) 219-226
10. Madras J, Lapointe H. Keratocystic odontogenic tumour: reclassification of the odontogenic keratocyst from cyst to tumour. J Can Dent Assoc. 2008;74:165-165h.
11. Meara J.G., Shah S., Li K.K., and Cunningham M.J. The odontogenic keratocyst: a 20-year clinicopathologic review. Laryngoscope 108 (1998) 280-283
12. Kuroyanagi N., Sakuma H., Miyabe S., Machida J., Kaetsu A., Yokoi M., et al. Prognostic factors for keratocystic odontogenic tumor (odontogenic keratocyst): analysis of clinico-pathologic and immunohistochemical findings in cysts treated by enucleation. J Oral Pathol Med 38 (2009) 386-392
13. Shear M. The aggressive nature of the odontogenic keratocyst: is it a benign cystic neoplasm? Part 2: proliferation and genetic studies. Oral Oncol 38 (2002) 323-331
14. Myoung H., Hong S.P., Hong S.D., et al. Odontogenic keratocyst: review of 256 cases for recurrence and clinicopathologic parameters. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91 (2001) 328-333
15. Stoelinga P.J. Long-term follow-up on keratocysts treated according to a defined protocol. Int J Oral Maxillofac Surg 30 (2001) 14-25
16. Kubota Y., Oka S., Nakagawa S., and Shirasuna K. Interleukin-1alpha enhances type I collagen-induced activation of matrix metalloproteinase-2 in odontogenic keratocyst fibroblasts. J Dent Res 81 (2002) 23-27
17. Oliveira M.D., Souza L.B., Pinto L.P., and Freitas R.A. Immunohistochemical study of components of the basement membrane in odontogenic cysts. Pesqui Odontol Bras 16 (2002) 157-162
18. de Paula A.M., Carvalhais J.N., Domingues M.G., Barreto D.C., and Mesquita R.A. Cell proliferation markers in the odontogenic keratocyst: effect of inflammation. J Oral Pathol Med. 29 (2000) 477-482
19. Piattelli A., Fioroni M., Santinelli A., and Rubini C. P53 protein expression in odontogenic cysts. J Endod 27 (2001) 459-461
20. Vogelstein B., Fearon E.R., Hamilton S.R., et al. Genetic alterations during colorectal-tumor development. N Engl J Med 319 (1988) 525-532
21. Fearon E.R., and Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 61 (1990) 759-767
22. Liotta L.A., and Stetler-Stevenson W.G. Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 51 (1991) 5054s-5059s
23. Stetler-Stevenson W.G., Aznavoorian S., and Liotta L.A. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 9 (1993) 541-573
24. Tucker A.S., and Sharpe P.T. Molecular genetics of tooth morphogenesis and patterning: the right shape in the right place. J Dent Res 78 (1999) 826-834
25. Jernvall J., and Thesleff I. Reiterative signaling and patterning during mammalian tooth morphogenesis. Mech Dev 92 (2000) 19-29
26. Stass S.A., and Mixson J. Oncogenes and tumor suppressor genes: therapeutic implications. Clin Cancer Res 3 (1997) 2687-2695
27. Weinberg R.A. Tumor suppressor genes. Science 254 (1991) 1138-1146
28. Knudson A.G. Antioncogenes and human cancer. Proc Natl Acad Sci USA 90 (1993) 10914-10921
29. Knudson Jr. A.G. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68 (1971) 820-823
30. Barreto D.C., Bale A.E., De Marco L., and Gomez R.S. Immunolocalization of PTCH protein in odontogenic cysts and tumors. J Dent Res 81 (2002) 757-760
31. Kumamoto H., Ohki K., and Ooya K. Expression of Sonic Hedgehog (SHH) signaling molecules in ameloblastomas. J Oral Pathol Med 33 (2004) 185-190
32. Kumamoto H. Molecular pathology of odontogenic tumors. J Oral Pathol Med 35 (2006) 65-74
33. Zhang Y.D., Chen Z., Song Y.Q., Liu C., and Chen Y.P. Making a tooth: growth factors, transcription factors, and stem cells. Cell Res 15 (2005) 301-316
34. Ingham P.W., Taylor A.M., and Nakano Y. Role of the drosophila patched gene in positional signalling. Nature 353 (1991) 184-187
35. Hardcastle Z., Hui C.C., and Sharpe P.T. The SHH signalling pathway in early tooth development. Cell Mol Biol 45 (1999) 567-568
36. Dassule H.R., Lewis P., Bei M., Maas R., and McMahon A.P. Sonic Hedgehog regulates growth and morphogenesis of the tooth. Development 127 (2000) 4775-4785
37. Cobourne M.T., Miletich I., and Sharpe P.T. Restriction of Sonic Hedgehog signalling during early tooth development. Development 131 (2004) 2875-2885
38. McMahon A.P. More surprises in the Hedgehog signalling pathway. Cell 100 (2000) 185-188
39. Ingham P.W. McMahon AP: Hedgehog signalling in animal development: paradigms and principles. Genes Dev 12 (2001) 3059-3087
40. Thayer S.P., di Magliano M.P., Heiser P.W., Nielsen C.M., Roberts G.Y., Lauwers G.Y., et al. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 425 (2003) 851-856
41. Nishimaki H., Kasai K., Kozaki K., Takeo T., Ikeda H., Saga S., et al. Role of activated Sonic Hedgehog signaling for the cellular proliferation of oral squamous cell carcinoma cell line. Biochem Biophys Res Commun 314 (2004) 313-320
42. Barnes E.A., Heidtman K.J., and Donoghue D.J. Constitutive activation of the shh-ptc1 pathway by a patched1 mutation identified in BCC. Oncogene 24 (2005) 902-915
43. Thievessen I., Wolter M., Prior A., Seifert H.H., and Schulz W.A. Hedgehog signaling in normal urothelial cells and in urothelial carcinoma cell lines. J Cell Physiol 203 (2005) 372-377
44. Levanat S., Musani V., Komar A., and Oreskovic S. Role of the Hedgehog/patched signaling pathway in oncogenesis: a new polymorphism in the PTCH gene in ovarian fibroma. Ann NY Acad Sci 1030 (2004) 134-143
45. Oniscu A., James R.M., Morris R.G., Bader S., Malcomson R.D., and Harrison D.J. Expression of Sonic Hedgehog pathway genes is altered in colonic neoplasia. J Pathol 203 (2004) 909-917
46. Shiotani A., Iishi H., Uedo N., Ishiguro S., Tatsuta M., Nakae Y., et al. Evidence that loss of Sonic Hedgehog is an indicator of helicobater pylori-induced atrophic gastritis progressing to gastric cancer. Am J Gastroenterol 100 (2005) 581-587
47. Sanchez P., Hernandez A.M., Stecca B., Kahler A.J., DeGueme A., Barrett A., et al. Inhibition of prostate cancer proliferation by interference with Sonic Hedgehog-GLI1 signaling. Proc Natl Acad Sci USA 101 (2004) 12561-12566
48. Cengel K.A. Targeting Sonic Hedgehog: a new way to move down pancreatic cancer?. Cancer Biol Ther 3 (2004) 165-166
49. Ohki K., Kumamoto H., Ichinohasama R., Sato T., Takahashi N., Ooya K., et al. PTC, SMO and GLI-1 in odontogenic keratocysts. Int J Oral Maxillofac Surg 33 (2004) 584-592
50. Yagyuu T., Kirita T., Sasahira T., Moriwaka Y., Yamamoto K., and Kuniyasu H. Recurrence of keratocystic odontogenic tumor: clinicopathological features and immunohistochemical study of the Hedgehog signaling pathway. Pathobiology 75 (2008) 171-176
51. Farndon P.A., Del Mastro R.G., Evans D.G., and Kilpatrick M.W. Location of gene for Gorlin syndrome. Lancet 339 (1992) 581-582
52. Lench N.J., High A.S., Markham A.F., Hume W.J., and Robinson P.A. Investigation of chromosome 9q22.3-q31 DNA marker loss in odontogenic keratocysts. Eur J Cancer B Oral Oncol 32B (1996) 202-206
53. Lench N.J., Telford E.A., High A.S., Markham A.F., Wicking C., and Wainwright B.J. Characterization of human patched germ line mutations in nevoid basal cell carcinoma syndrome. Hum Genet 100 (1997) 497-502
54. Barreto D.C., Gomez R.S., Bale A.E., Boson W.L., and De Marco L. PTCH gene mutation in odontogenic keratocysts. J Dent Res 79 (2000) 1418-1422
55. Reis A., Kuster W., Linss G., Gebel E., Hamm H., Fuhrmann W., et al. Localisation of gene for naevoid basal cell carcinoma syndrome. Lancet 339 (1992) 617
56. Levanat S., Gorlin R.J., Fallet S., Johnson D.R., Fantasia J.E., and Bale A.E. A two-hit model for developmental defects in Gorlin syndrome. Nat Genet 12 (1996) 85-87
57. Lo Muzio L., Staibanot S., Pannone G., et al. Expression of cell cycle and apoptosis-related proteins in sporadic odontogenic keratocysts and odontogenic keratocysts associated with the nevoid basal cell carcinoma syndrome. J Dent Res 78 (1999) 1345-1353
58. Yamamoto K., Yoshihashi H., Furuya N., Adachi M., Ito S., Tanaka Y., et al. Further delineation of 9q22 deletion syndrome associated with basal cell nevus (Gorlin) syndrome: report of two cases and review of the literature. Congenit Anom (Kyoto) 49 (2009) 8-14
59. Brellier F., Bergoglio V., Valin A., Barnay S., Chevallier-Lagente O., Vielh P., et al. Heterozygous mutations in the tumor suppressor gene PATCHED provoke basal cell carcinoma-like features in human organotypic skin cultures. Oncogene 27 (2008) 6601-6606
60. Santarosa M., and Ashworth A. Haploinsufficiency for tumour suppressor genes: when you don't need to go all the way. Biochim Biophys Acta 1654 (2004) 105-122
61. Li T.J., Browne R.M., and Matthews J.B. Expression of epidermal growth factor receptors by odontogenic jaw cysts. Virchows Arch A Pathol Anat Histopathol 423 (1993) 137-144
62. Li T.J., Browne R.M., and Matthews J.B. Immunocytochemical expression of growth factors by odontogenic jaw cysts. Mol Pathol 50 (1997) 21-27
63. Kumamoto H., Yoshida M., and Ooya K. Immunohistochemical detection of hepatocyte growth factor, transforming growth factor-b and their receptors in epithelial odontogenic tumors. J Oral Pathol Med 31 (2002) 539-548
64. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1 (1995) 27-31
65. Toi M., Taniguchi T., Yamamoto Y., Kurisaki T., Suzuki H., and Tominaga T. Clinical significance of the determination of angiogenic factors. Eur J Cancer 32A (1996) 2513-2519
66. Ferrara N., and Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 18 (1997) 4-25
67. Kumamoto H., Ohki K., and Ooya K. Association between vascular endothelial growth factor (VEGF) expression and tumor angiogenesis in ameloblastomas. J Oral Pathol Med 31 (2002) 28-34
68. Ogden G.R., Chisholm D.M., Kiddie R.A., and Lane D.P. P53 protein in odontogenic cysts: increased expression in some odontogenic keratocysts. J Clin Pathol 45 (1992) 1007-1010
69. Slootweg P.J. P53 protein and Ki-67 reactivity in epithelial odontogenic lesions. An immunohistochemical study. J Oral Pathol Med 24 (1995) 393-397
70. Lombardi T., Odelll E.W., and Morgan P.R. P53 immunohistochemistry of odontogenic keratocysts in relation to recurrence, basal cell budding and basal-cell naevus syndrome. Arch Oral Biol 40 (1995) 1081-1084
71. Li T.J., Browne R.M., Prime S.S., Paterson I.C., and Matthews J.B. P53 expression in odontogenic keratocyst epithelium. J Oral Pathol Med 25 (1996) 245-255
72. El Murtadi A., Grehan D., Toner M., and Mc Cartan B.E. Proliferating cell nuclear antigen staining in syndrome and nonsyndrome odontogenic keratocysts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 81 (1996) 217-220
73. Piattelli A., Fioroni M., Santinelli A., and Rubini C. Expression of proliferating cell nuclear antigen in ameloblastomas and odontogenic cysts. Oral Oncol 34 (1998) 408-412
74. Kimi K., Kumamoto H., Ooya K., and Motegi K. Analysis of apoptosis-related factors and apoptotic cells in lining epithelium of odontogenic keratocysts. Oral Med Pathol 5 (2000) 35-40
75. Kimi K., Kumamoto H., Ooya K., and Motegi K. Immunohistochemical analysis of cell-cycle- and apoptosis-related factors in lining epithelium of odontogenic keratocysts. J Oral Pathol Med 30 (2001) 434-442
76. Kim D.K., Ahn S.G., Kim J., and Yoon J.H. Comparative Ki-67 expression and apoptosis in the odontogenic keratocyst associated with or without an impacted tooth in addition to unilocular and multilocular varieties. Yonsei Med J 44 (2003) 841-846
77. Kichi E., Enokiya Y., Muramatsu T., Hashimoto S., Inoue T., Abiko Y., et al. Cell proliferation, apoptosis and apoptosis-related factors in odontogenic keratocysts and in dentigerous cysts. J Oral Pathol Med 34 (2005) 280-286
78. Schmitt C.A., and Lowe S.W. Apoptosis and therapy. J Pathol 187 (1999) 127-137
79. Li T.J., Browne R.M., and Matthews J.B. Quantification of PCNA+ cells within odontogenic jaw cyst epithelium. J Oral Pathol Med 23 (1994) 184-189
80. González-Moles M.A., Mosqueda-Taylor A., Delgado-Rodríguez M., Martínez-Mata G., Gil-Montoya J.A., Díaz-Franco M.A., et al. Analysis of p53 protein by PAb240, Ki-67 expression and human papillomavirus DNA detection in different types of odontogenic keratocyst. Anticancer Res 26 (2006) 175-181
81. Li T.J., Browne R.M., and Matthews J.B. Epithelial cell proliferation in odontogenic keratocysts: immunocytochemical study of Ki67 in simple, recurrent and basal cell naevus syndrome (BCNS)-associated lesions. J Oral Pathol Med 24 (1995) 221-226
82. Lu Q.L., Abel P., Foster C.S., and Lalani E.N. Bcl-2: role in epithelial differentiation and oncogenesis. Human Pathol 27 (1996) 102-110
83. Chylicki K., Ehinger M., Svedberg H., and Gullberg U. Characterization of the molecular mechanisms for p53-mediated differentiation. Cell Growth Differ 11 (2000) 561-571
84. Kumamoto H. Detection of apoptosis-related factors and apoptotic cells in ameloblastomas: analysis by immunohistochemistry and an in situ DNA nick end-labelling method. J Oral Pathol Med 26 (1997) 419-425
85. Mitsuyasu T., Harada H., Higuchi Y., et al. Immunohistochemical demonstration of bcl-2 protein in ameloblastoma. J Oral Pathol Med 26 (1997) 345-348
86. Singh B.B., Chandler Jr. F.W., Whitaker S.B., and Forbes-Nelson A.E. Immunohistochemical evaluation of bcl-2 oncoprotein in oral dysplasia and carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85 (1998) 692-698
87. Tosios K.I., Angelopoulou K., and Kapranos N. Immunohistochemical study of bcl-2 protein, Ki-67 antigen and p53 protein in epithelium of glandular odontogenic cysts and dentigerous cysts. J Oral Pathol Med 29 (2000) 139-144
88. Slootweg P.J., and De Weger R.A. Immunohistochemical demonstration of bcl-2 protein in human tooth germs. Arch Oral Biol 39 (1994) 545-550
89. Vedtofte P., Holmstrup P., and Dabelsteen E. Human odontogenic keratocyst transplants in nude mice. Scand J Dent Res 90 (1982) 306-314
90. Kaplan I., and Hirshberg A. The correlation between epithelial cell proliferation and inflammation in odontogenic keratocyst. Oral Oncol 40 (2004) 985-991
91. Meghji S., Henderson B., Bando Y., and Harris M. Interleukin-1: the principal osteolytic cytokine produced by keratocysts. Arch Oral Biol 37 (1992) 935-943
92. Lader C.S., and Flanagan A.M. Prostaglandin E2, interleukin 1a, and tumor necrosis factor-a increase human osteoclast formation and bone resorption in vitro. Endocrinology 139 (1998) 3157-3164
93. Tani-Ishii N., Tsunoda A., Teranaka T., and Umemoto T. Autocrine regulation of osteoclast formation and bone resorption by IL-1α and TNFα. J Dent Res 78 (1999) 1617-1623
94. Dayer J.-M., de Rochemonteix B., Burrus B., Demczuk S., and Dinarello C.A. Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells. J Clin Invest 77 (1986) 645-648
95. Saito S., Ngan P., Rosol T., et al. Involvement of PGE synthesis in the effect of intermittent pressure and interleukin-1β on bone resorption. J Dent Res 70 (1991) 27-33
96. Tewari M., Tuncay O.C., Milchman A., et al. Association of interleukin-1-induced, NFΚB DNA-binding activity with collagenase gene expression in human gingival fibroblasts. Arch Oral Biol 41 (1996) 461-468
97. Kusano K., Miyaura C., Inada M., et al. Reguration of matrix metalloproteinase (MMP-2-3-9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: association of MMP induction with bone resorption. Endocrinology 139 (1998) 1338-1345
98. Kubota Y., Ninomiya T., Oka S., Takenoshita Y., and Shirasuna K. Interleukin-1α dependent regulation of matrix metalloproteinase-9 (MMP-9) secretion and activation in the epithelial cells of odontogenic jaw cysts. J Dent Res 79 (2000) 1423-1430
99. Ogata S., Kubota Y., Yamashiro T., Takeuchi H., Ninomiya T., Suyama Y., et al. Signaling pathways regulating IL-1alpha-induced COX-2 expression. J Dent Res 86 (2007) 186-191
100. Meghji S., Qureshi W., Henderson B., and Harris M. The role of endotoxin and cytokines in the pathologenesis of odontogenic cysts. Arch Oral Biol 41 (1996) 523-531
101. Maas-Szabowski N., Shimotoyodome A., and Fusenig N.E. Keratinocyte growth regulation in fibroblast cocultures via a double paracrine mechanism. J Cell Sci 112 (1999) 1843-1853
102. Ninomiya T., Kubota Y., Koji T., and Shirasuna K. Marsupialization inhibits interleukin-1alpha expression and epithelial cell proliferation in odontogenic keratocysts. J Oral Pathol Med 31 (2002) 526-533
103. Taipale J., Chen J.K., Cooper M.K., Wang B., Mann R.K., Milenkovic L., et al. Effects of oncogenic mutations in smoothened and patched can be reversed by cyclopamine. Nature 406 (2000) 1005-1009
104. Arad S., Zattra E., Hebert J., Epstein Jr. E.H., Goukassian D.A., and Gilchrest B.A. Topical thymidine dinucleotide treatment reduces development of ultraviolet-induced basal cell carcinoma in Ptch-1+/- mice. Am J Pathol. 172 (2008) 1248-1255
105. Williams J.A., Guicherit O.M., Zaharian B.I., Xu Y., Chai L., Wichterle H., et al. Identification of a small molecule inhibitor of the Hedgehog signaling pathway: effects on basal cell carcinoma-like lesions. Proc Natl Acad Sci USA 100 (2003) 4616-4621
106. Zhang L., Sun Z.J., Zhao Y.F., Bian Z., Fan M.W., and Chen Z. Inhibition of SHH signaling pathway: molecular treatment strategy of odontogenic keratocyst. Med Hypotheses 67 (2006) 1242-1244
107. Stolina M., Sharma S., Lin Y., et al. Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis. J Immunol 164 (2000) 361-370